CA3124439C - Forme posologique contenant de l'acetate d'abiraterone - Google Patents

Forme posologique contenant de l'acetate d'abiraterone

Info

Publication number
CA3124439C
CA3124439C CA3124439A CA3124439A CA3124439C CA 3124439 C CA3124439 C CA 3124439C CA 3124439 A CA3124439 A CA 3124439A CA 3124439 A CA3124439 A CA 3124439A CA 3124439 C CA3124439 C CA 3124439C
Authority
CA
Canada
Prior art keywords
optionally
surfactant
binder
dosage form
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3124439A
Other languages
English (en)
Other versions
CA3124439A1 (fr
Inventor
Panagiotis Panagopoulos
Konstantinos-Emmanouil Panitsas
Pandora Alexaki
Dimosthenis Kantas
George Vachratidis
John Vouvalidis
Christina Michali
Charalambos Pattihis
Antje Nordmann
Michalis Neoptolemou
Original Assignee
REMEDICA Ltd
PHARMACEUTICAL ORIENTED SERVICES Ltd
Filing date
Publication date
Application filed by REMEDICA Ltd, PHARMACEUTICAL ORIENTED SERVICES Ltd filed Critical REMEDICA Ltd
Priority claimed from PCT/EP2018/086401 external-priority patent/WO2020126017A1/fr
Publication of CA3124439A1 publication Critical patent/CA3124439A1/fr
Application granted granted Critical
Publication of CA3124439C publication Critical patent/CA3124439C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne une forme posologique unitaire solide pour administration orale, de préférence, un comprimé, contenant de l'acétate d'abiratérone, la forme posologique unitaire solide étant préparée par granulation par voie humide. La forme posologique unitaire solide est destinée au traitement du cancer de la prostate.
CA3124439A 2018-12-20 Forme posologique contenant de l'acetate d'abiraterone Active CA3124439C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2018/086401 WO2020126017A1 (fr) 2018-12-20 2018-12-20 Forme posologique contenant de l'acétate d'abiratérone

Publications (2)

Publication Number Publication Date
CA3124439A1 CA3124439A1 (fr) 2020-06-25
CA3124439C true CA3124439C (fr) 2026-04-07

Family

ID=

Similar Documents

Publication Publication Date Title
US12403140B2 (en) Pharmaceutical compositions of nilotinib
US20090304795A1 (en) Tablets with improved drug substance dispersibility
KR100962447B1 (ko) 난용성 약물인 두타스테라이드의 자가유화 조성물과 이로부터 제조된 정제
JP2004504360A (ja) １−（５−ｔｅｒｔ−ブチル−２−Ｐ−トリル−２Ｈ−ピラゾール−３−イル）−３−［４−（２−モルホリン−４−イル−エトキシ）−ナフタレン−１−イル］−ウレアの改良された経口製剤
EP2595607A2 (fr) Médicament d'administration orale contenant un mélange de silodosine et d'un copolymère basique
WO2022013360A1 (fr) Composition pharmaceutique comprenant un ivacaftor
US7115281B2 (en) Processes for the preparation of oral dosage formulations of modafinil
EP3793530A1 (fr) Dispersion solide contenant du ritonavir
EP3620156A1 (fr) Composition ayant une solubilité dans l'eau et une biodisponibilité améliorées
AU2014295100B2 (en) Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and its process of preparation.
CA3124439C (fr) Forme posologique contenant de l'acetate d'abiraterone
US20100003319A1 (en) Raloxifene immediate release tablets
AU2018454263B2 (en) Dosage form containing abiraterone acetate
US11260055B2 (en) Oral pharmaceutical composition of lurasidone and preparation thereof
US20250144100A1 (en) Pharmaceutical composition comprising ibrutinib
EP3761965A1 (fr) Formulation de comprimé contenant du ticagrelor
RU2821950C2 (ru) Новая композиция лапатиниба в виде твердой лекарственной формы для перорального применения и способ ее изготовления
WO2025017072A1 (fr) Compositions pharmaceutiques stables d'un inhibiteur de cyp11a1
WO2023126973A1 (fr) Composition pharmaceutique stable d'elagolix
EP3846787A1 (fr) Nouvelle composition de lapatinib de forme galénique orale solide et procédé de fabrication
EP2363120A1 (fr) Mélange contenant du diméboline et de la mémantine